EL vs ZYME · rev $15.05B vs rev $76.3M
Estee Lauder Companies Inc (EL) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
EL currently screens at market cap $31.92B. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the EL and ZYME stock pages for the full models.
Not investment advice.